Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glutamate Receptor”

Showing 11 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00113022
What this trial is testing

Org 24448 to Treat Major Depression

Who this might be right for
Depression
National Institute of Mental Health (NIMH) 9
Large-scale testing (Phase 3)Study completedNCT04039022
What this trial is testing

Open-Label Safety Study of AXS-05 in Subjects With Depression

Who this might be right for
Major Depressive DisorderTreatment Resistant DepressionDepression
Axsome Therapeutics, Inc. 876
Testing effectiveness (Phase 2)Study completedNCT00108667
What this trial is testing

Talampanel to Treat Parkinson's Disease

Who this might be right for
Parkinson Disease
National Institute of Neurological Disorders and Stroke (NINDS) 40
Post-approval studies (Phase 4)Study completedNCT01108029
What this trial is testing

Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease

Who this might be right for
Parkinson's DiseaseGait Disorders, Neurologic
University Hospital, Lille 28
Early research (Phase 1)Study completedNCT01546051
What this trial is testing

BCI-838 and Several BCI-632 Prodrugs in Healthy Volunteers

Who this might be right for
Healthy
BrainCells Inc. 31
Testing effectiveness (Phase 2)Study completedNCT00001929
What this trial is testing

Treatment of Parkinson's Disease With Eliprodil

Who this might be right for
Movement DisordersParkinson Disease
National Institute of Neurological Disorders and Stroke (NINDS) 20
Testing effectiveness (Phase 2)UnknownNCT03651557
What this trial is testing

Antioxidant and NMDA Receptor Blocker Wins Anoxic Brain Damage of KorEa OHCA Patients

Who this might be right for
Cardiac Arrest
GNT Pharma 150
Testing effectiveness (Phase 2)Study completedNCT00004576
What this trial is testing

Study of LY300164 for the Treatment of Parkinson's Disease

Who this might be right for
DyskinesiasParkinson Disease
National Institute of Neurological Disorders and Stroke (NINDS) 20
Testing effectiveness (Phase 2)Looking for participantsNCT07432958
What this trial is testing

Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

Who this might be right for
Parkinson Disease
Appello Pharmaceuticals, Inc. 150
Not applicableStudy completedNCT04350567
What this trial is testing

Sleep/Wake Cycle and Depression: An Imaging and Treatment Study

Who this might be right for
Depression; Major Depressive Disorder
Stony Brook University 61
Not applicableStudy completedNCT02230592
What this trial is testing

PET Imaging of Brain mGluR1 Receptors Using [18F]FIMX

Who this might be right for
Anxiety DisorderMajor Depressive Disorder
National Institute of Mental Health (NIMH) 19

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation